AUG 15, 2021 5:52 PM PDT

A COVID-19 Vaccine Booster Now Recommended for Immunocompromised People

WRITTEN BY: Carmen Leitch

As Delta has become the dominant SARS-CoV-2 variant causing COVID-19 infections in the United States, researchers and health officials have been trying to determine whether the current vaccines can protect against this particularly contagious variant. Right now, the answer seems to be yes, the mRNA vaccines produced by Pfizer and Moderna are effective against the Delta variant, especially at preventing hospitalizations and deaths.

However, recent pre-printed work (not yet peer-reviewed) has suggested that the efficacy of these vaccines may decline as more unvaccinated people become infected and contagious. However, the work needs to be evaluated further before we can draw solid conclusions from it. Learn more about breakthrough infections from the video.

Related: COVID-19 Delta Variant Seems to Grow Faster & Be More Contagious

Officials are understandably eager to get as may people vaccinated as possible, for many reasons. For example, it's important to reduce the strain on our healthcare system, and the faster we can reduce the spread of the SARS-CoV-2 virus, the fewer chances it will have to mutate into other variants as well.

The Centers for Disease Control and Prevention (CDC), the Food and Drug Administration and other organizations are beginning to assess whether COVID-19 vaccine booster shots will be needed.

Colorized scanning electron micrograph of a cell (teal and green) infected with SARS-CoV-2 virus particles (purple and pink), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID

As of August 13, 2021, vaccine boosters have been authorized for a small number of people in select groups. According to CDC recommendations, the following individuals are eligible to receive an additional dose of the 2-dose vaccine they received. It's too soon to know whether an additional dose of the Johnson & Johnson (J&J) vaccine will provide any additional protection, so another J&J dose is not recommended at this time. Patients on the following list (copied directly from the CDC) who got a Pfizer vaccine should get another Pfizer dose if desired, and those who received a Moderna vaccine would get another Moderna dose if desired.

  •     "Active treatment for solid tumor and hematologic malignancies
  •     Receipt of solid-organ transplant and taking immunosuppressive therapy
  •     Receipt of CAR-T-cell or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy)
  •     Moderate or severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome)
  •     Advanced or untreated HIV infection
  •     Active treatment with high-dose corticosteroids (i.e., ≥20mg prednisone or equivalent per day), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, tumor-necrosis (TNF) blockers, and other biologic agents that are immunosuppressive or immunomodulatory."

Right now, COVID-19 is surging in the United States again. About 129,000 new cases are being reported daily. It's estimated that 51 percent of Americans are fully vaccinated and about 60 percent have gotten one dose. Right now, approval to give the COVID-19 vaccines to children under age 12 is expected around mid-winter, though the United States is asking for approval to be fast-tracked. Results from trials are expected in the fall, and those results will have to be reviewed.

Researchers will be continuing to assess whether boosters will be needed for the elderly, or the general population. Unfortunately, the general public is unaccustomed to rapidly-changing and updated information regarding infectious disease, and keeping up with these shifts in knowledge has been challenging and confusing for many.

Source: CDC

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
APR 20, 2021
Chemistry & Physics
Warning: public restroom ahead, high levels of aerosol particles
APR 20, 2021
Warning: public restroom ahead, high levels of aerosol particles
New research on the aerosolization of pathogens provides recommendations for public restroom use. According to the study ...
MAY 14, 2021
Coronavirus
How COVID-19 Patients Lose Their Sense of Smell
MAY 14, 2021
How COVID-19 Patients Lose Their Sense of Smell
The loss of the sense of smell is a well-known symptom of COVID-19, and was common even in people that did not have many ...
JUL 08, 2021
Technology
Digital "Pass" for Confirming COVID-19 Infection Status Goes Open Source
JUL 08, 2021
Digital "Pass" for Confirming COVID-19 Infection Status Goes Open Source
As the world starts to emerge from the coronavirus pandemic and seek some sense of normalcy again, people still have a l ...
JUL 16, 2021
Technology
Echocardiogram May Help Predict COVID-19 Patients at Risk for Heart Complications
JUL 16, 2021
Echocardiogram May Help Predict COVID-19 Patients at Risk for Heart Complications
Researchers learned early on in the pandemic that COVID-19 infections caused a range of complications throughout the bod ...
JUL 28, 2021
Technology
Addressing The Environmental Impact Of Disposable Masks
JUL 28, 2021
Addressing The Environmental Impact Of Disposable Masks
At the height of the COVID-19 pandemic, mask wearing was a regular part of life as governments imposed mandates to help ...
SEP 07, 2021
Health & Medicine
Vaccines- a Long History of Cost-Benefit Analysis
SEP 07, 2021
Vaccines- a Long History of Cost-Benefit Analysis
Vaccination and new treatments for diseases have remained topics of skepticism since their inception. When it came to an ...
Loading Comments...